Regulation of carnitine transporters secretory pathway by AKT - a kinase hyperactivated in cancer cells

2018/31/B/NZ3/00669

Keywords

Descriptors

  • NZ3_1: Biologia komórki
  • NZ3_7: Przekaźnictwo sygnału
  • NZ3_2: Fizjologia komórki

Panel

NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Katarzyna Anna Nałęcz

Number of co-investigators in the project: 3

Call

OPUS 16 – announced on 2018-09-14

Amount awarded
1 275 200 PLN
Project start date
2019-07-01
Project end date
2022-12-31
Project duration
42 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Aparat do elektroforezy. Cost: 2 468 PLN
  2. Cieplarka 37oC do hodowli bakteryjnych. Cost: 8 000 PLN
  3. Inkubator CO2 do hodowli komórkowych typu "Cell Locker" z wnętrzem z miedzi, z filtrami. Cost: 94 000 PLN

Information in the final report

Publication in academic press/journals (4)

  1. Trafficking of the cell surface amino acid transporter SLC6A14 upregulated in cancer is controlled by phosphorylation of SEC24C protein by AKT knase

    Authors:
    Kovalchuk V., Nalecz K.A.
    Academic press:
    Cells (year: 2021, volume: 10, pages: 18000), Publisher: MDPI
    Status:
    Published
  2. The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase

    Authors:
    Papierniak-Wyglądała A., Lamch W., Jurewicz E. , Nałęcz K.A.
    Academic press:
    Archives of Biochemistry and Biophysics (year: 2023, volume: 742, pages: 109616), Publisher: Elsevier
    Status:
    Published
  3. Amino acid transporter SLCA14 (ATB0,+) – A target in combined anti-cancer therapy

    Authors:
    Nałęcz K.A.
    Academic press:
    Front. Cell Dev. Biol. (year: 2020, volume: 8, pages: 46035), Publisher: Frontiers
    Status:
    Published
    DOI:
    10.3389/fcell.2020.594464. – link to the publication
  4. SLC22A5 (OCTN2) Carnitine Transporter - Indispensable for Cell metabolism, a Jekyll and Hyde of Human Cancer

    Authors:
    Juraszek B.,, Nałęcz K.A.
    Academic press:
    Molecules (year: 2020, volume: 25, pages: 14), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules25010014 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski